This trial looks at two ways of diagnosing prostate cancer to see which is more accurate.
- Unknown Health Status
- Elevated Prostate Specific Antigen (PSA)
1 Primary · 1 Secondary · Reporting Duration: Up to 5 years
Awards & Highlights
2 Treatment Groups
Arm I (SR-Bx)
1 of 2
Arm II (MRI, MRUS-Bx, SR-Bx)
1 of 2
400 Total Participants · 2 Treatment Groups
Primary Treatment: Biopsy of Prostate · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Male Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many centers are implementing this trial currently?
"Multiple medical centres have begun recruiting for this clinical trial, including the University of Maryland in Baltimore, UT Southwestern/Simmons Cancer Center-Dallas in Dallas and USC / Norris Comprehensive Cancer Centre in Los Angeles. Additionally, four other research sites are also enrolling participants." - Anonymous Online Contributor
Is recruitment for this investigation actively taking place?
"According to clinicaltrials.gov, this medical investigation is actively seeking volunteers. The trial was initially posted on September 25th 2017 and most recently updated on August 5th 2022." - Anonymous Online Contributor
What is the current size of enrolment for this trial?
"Affirmative. The clinical trial is still looking for individuals to take part in the study and its details were last updated on August 5th 2022, as seen on clinicaltrials.gov. 400 persons must be recruited from 7 different medical sites before the research can begin." - Anonymous Online Contributor